التفاصيل البيبلوغرافية
| العنوان: |
Eli Lilly&Company SWOT Analysis. |
| المصدر: |
Eli Lilly&Company SWOT Analysis; Mar2015, p1-10, 10p |
| مصطلحات موضوعية: |
PHARMACEUTICAL industry, SWOT analysis, BUSINESS finance, BUSINESS cycles, FINANCIAL performance, CORPORATE profits, CORPORATE growth |
| الشركة/الكيان: |
ELI Lilly & Co. |
| مستخلص: |
A business analysis of pharmaceutical company Eli Lilly & Co. is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company as of March 2015. Strengths include its leadership position in the global diabetes market. Weaknesses include its loss of patent exclusivity. Opportunities include its partnership with rival Pfizer to develop tanezumab. Threats include the setback in the development of late stage product candidates for Alzheimer's disease. |
| قاعدة البيانات: |
Complementary Index |
